Navigation Links
Debiopharm Group and Moffitt Cancer Center Sign Development and Commercialisation Agreement for Small Molecule Debio 0928 in Early Preclinical Development for Treatment of Solid Tumours
Date:6/18/2009

LAUSANNE, Switzerland and TAMPA, Florida, June 18 /PRNewswire/ -- Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and Moffitt Cancer Center (Moffitt), a non-profit Florida corporation, announce the signature of an exclusive license agreement for the development and commercialization of Debio 0928, a small molecule in early preclinical development that inhibits the protein-protein interaction between Raf-1 (key signalling kinase in the MAP kinase pathway) and Rb (retinoblastoma protein). Rb acts as a barrier to cell division and proliferation. However, when Raf-1 physically interacts with Rb, it triggers a cascade of signals that eventually overcomes this barrier, thus inducing cellular proliferation. By preventing the interaction between Raf-1 and Rb and blocking the cell cycle, Debio 0928 creates a new strategy in the fight against cancer and is thus a potentially promising novel anti-tumour drug.

Under the terms of the agreement, Debiopharm shall pay Moffitt an up-front fee, as well as predefined advanced milestone payments during the development of Debio 0928. First entry of the product into man is expected for 2012.

"This discovery, made by the collaboration between Drs. Srikumar Chellappan, Said Sebti, and Nicholas Lawrence at Moffitt, is a novel approach to the treatment of cancer," said Rolland-Yves Mauvernay, President and Founder of Debiopharm Group. "Being able to de-activate a key signalling kinase like Raf-1, known to be involved in many types of cancer, could open the door to more effective oncology treatments in the future."

"The disruption of the binding of the tumour promoter Raf-1 to the tumour suppressor Rb with Debio 0928 is a novel, first-in-class therapeutic strategy that has the potential for targeting a wide spectrum of human cancers," added
'/>"/>

SOURCE Debiopharm Group
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Debiopharm and Pharmaleads Sign License Agreement for Debio 0827 or PL37 in Treatment of Chronic Pain Conditions
2. Debiopharm and Aurigene Sign Licensing Agreement for the Development and Commercialisation of Debio 0617, a Novel Inhibitor of an Undisclosed Oncology Pathway
3. Japanese Cancer Association and Debiopharm Honour Japanese Research
4. Debiopharm Signs License Agreement for Marketing of Salvacyl(R)/Moapar(R) 3-Month in Treatment of Sexual Deviations
5. Debiopharm and EPFL Establish an Oncology Chair
6. Japanese Cancer Association and Debiopharm Honour Professors Minoru Toyota and Keiichi Nakayama With the 2007 JCA-Mauvernay Award
7. Debiopharm Receives cGMP Certification for Quality Control of its Drug Products
8. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
9. Digital Healthcare Specialist Cadient Group Ranked #2 on List of Full-service Advertising Agencies in the Philadelphia Region
10. PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June
11. Cadient Group Brings Home the Gold and Two Bronze Aster Awards

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...wswire/ - Cytochroma today announced the appointme...Dr. Moldt will replace Mr. Ulrik Spork as the Novo...mber of Board members remains unchanged at six mem...Moldt to the board and look forward to benefiting ...tinues to make progress in becoming a leading CKD-...
(Date:11/24/2009)...n . , Whether it,s CD packaging, containers ...y Identification) are increasingly finding their w...bel objects or goods and identify them automatical... read and process the data contained in the label....tion conditions of up to 100 degrees Celsius. But ...
(Date:11/24/2009)...v. 24 Two more prestigious univers...leading online job board and careers site for life...umbia University are now members of the job board,...itutions. ,, The job board, www.biocareercente...ences. While there are hundreds of life science ca...
(Date:11/24/2009)... employment grew by 29,000 jobs in October, and t...rowth during the U.S. recession. However, clinics ...lth systems are coming closer to having to actuall...ators. , (Vocus) November...ing in October despite the shedding of jobs in mos...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
... Drs. Frank Slack, Steven Johnson,... Kristy Reinert at Yale University, in , ...scovered that the , let-7 mic... of let-60/RAS in C. elegans e...d this work was extended to humans. As detailed in...
...ergence of more and , more sophistica..., array analysis, real-time RT-PCR), ...e studies has become increasingly critical. As The... to defining what "high , quality RNA... from , any source. Ambion,s newest R...
...ing RNA interference (RNAi) with , ...nly recently , been described i... have several advantages over oth...livery. Namely, these viruses can infect dividing ...an be used in animal model systems. , ...
Other Biology Technology:The let-7 microRNA Family Regulates RAS: Implications for Development and Oncogenesis 2The let-7 microRNA Family Regulates RAS: Implications for Development and Oncogenesis 3The let-7 microRNA Family Regulates RAS: Implications for Development and Oncogenesis 4The let-7 microRNA Family Regulates RAS: Implications for Development and Oncogenesis 5The let-7 microRNA Family Regulates RAS: Implications for Development and Oncogenesis 6The let-7 microRNA Family Regulates RAS: Implications for Development and Oncogenesis 7The let-7 microRNA Family Regulates RAS: Implications for Development and Oncogenesis 8SUPERIOR RNA FOR DEMANDING APPLICATIONS 2SUPERIOR RNA FOR DEMANDING APPLICATIONS 3SUPERIOR RNA FOR DEMANDING APPLICATIONS 4SUPERIOR RNA FOR DEMANDING APPLICATIONS 5SUPERIOR RNA FOR DEMANDING APPLICATIONS 6SUPERIOR RNA FOR DEMANDING APPLICATIONS 7Superior Gene Silencing Using Adenoviral Vectors 2Superior Gene Silencing Using Adenoviral Vectors 3Superior Gene Silencing Using Adenoviral Vectors 4Superior Gene Silencing Using Adenoviral Vectors 5
(Date:11/25/2009)..., On September 11, firefighters, police officers ...fort in the World Trade Center complex. They battl... searched for survivors, tackled fires and evacuat...ontained an estimated 17,000 people. And making th...nications: frightened workers and their relatives ...
(Date:11/25/2009)..., LA JOLLA, CAWhen you eat may be just as vital... at the Salk Institute for Biological Studies. The...ing and waning of thousands of genes in the livert...led by food intake and not by the body,s circadian...ding time determines the activity of a large numbe...
(Date:11/24/2009)..., Stents that keep weakened and flabby arteries f...er six months, those stents are no longer needed -...unnecessary. Previously, doctors had no choice but...n of Tel Aviv University,s Department of Biomedica...iber platform that carries drugs where they,re nee...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3Feeding the clock 2Feeding the clock 3A coating for life 2BD and FIND Achieve Milestone in Global Battle Against MDR TB 49701 1BD and FIND Achieve Milestone in Global Battle Against MDR TB 49701 2BD and FIND Achieve Milestone in Global Battle Against MDR TB 49701 3BD and FIND Achieve Milestone in Global Battle Against MDR TB 49701 4Federal Bureau of Investigation Awards Lockheed Martin Biometric Card Scanning Service Contract 8956 1Federal Bureau of Investigation Awards Lockheed Martin Biometric Card Scanning Service Contract 8956 2CetylMax 28R 29 and Flexadren 28R 29 Win Federal Lawsuit Court Rules Against Imagenetix 49696 1CetylMax 28R 29 and Flexadren 28R 29 Win Federal Lawsuit Court Rules Against Imagenetix 49696 2CetylMax 28R 29 and Flexadren 28R 29 Win Federal Lawsuit Court Rules Against Imagenetix 49696 3
...re generally discovered when the memory has alread...nska Institutet shows, however, that approaching A...e symptoms manifest themselves. , Dementia involv...ed by some kind of dementia disease of the brain, ...there is currently no cure for Alzheimer,s, it is ...
...ng as more and younger people dye their hair, warn...o dermatitis on the face and, in severe cases, fac...of hair dyes currently contain para-phenylenediami... century, allergic reactions to PPD became such a ...in Germany, France, and Sweden. , Current Europ...
... have found an underlying molecular cause for one ...een deafness and the organization of liquid crysta...n the cochlea of the inner ear, sound waves cause ...stimulate hair cells, which then trigger nerve imp...rchers have now learned that mutations in a protei...
Other Biology News:Gene tests and brain imaging reveal early dementia 2Scientists identify molecular cause for one form of deafness 2
...Cell Dissociation Buffers are membrane-filtered is...ts chelating agents and cell-conditioning agents i...solution or Ca2+- and Mg2+-free phosphate-buffere...s from support substrates and each other for studi...
...Kit Components , 25 g Blocking Reagent , 2 x...Buffer , 0.2 ml BL21 glycerol stock , 0.2 ml...ol stock , 1010 pfu T7Select Positive Control L...te , 50 l S-protein HRP Conjugate , 2 ml T7S...
...WesternBreeze Immunodetection Kits are designed fo...immobilized on nitrocellulose or PVDF membranes. S...embranes and primary antibodies), the WesternBreez...col and getting your final results. Solutions are ...
Mouse Anti-L1 Cell Adhesion Molecule Monoclonal Antibody, Unconjugated, Clone UJ127 from GeneTex
Biology Products: